Ivermectin has already been used by medical doctors in various countries with great success and positive results. Why is Ivermectin forbidden in South Africa, because the same medicine is available on various African countries and even Yemen and the results were excellent. Are those in charge of the vaccines afraid that it will be of a great success and with no harm, like in the countries in Africa, America, Australia etc. What happened to the medical doctors in South Africa today – do they have a right – do I as a citizen has a right? The scientific facts are not always correct either and the vaccines will only for a one year, what then – there will be still lockdowns and masks. And millions of unemployment all over. Is the other political parties voiceless? Only one or two parties went to stop this lockdowns.
Die siening word gehuldig, na die groot suksesse wat reeds oorsee op mense, in verskeie mediese hospitale en mediese praktyke behaal is met Ivermectin vir die corona virus, dat dit ook in Suid-Afrika beskikbaar gemaak moet word as ‘n dringende oplossing. Die middel is ook reeds in 1987 geregistreer.
Daar is reeds verskeie studies gedoen en inligting rakende die gebruik van Ivermectin groei steeds heelwat met positiewe resultate waar almal gesond word. Hoeveel leef in Suid-Afrika met die swaard van dood oor hul koppe, terwyl daar wel ‘n middel is wat hulle kan help.
Dieselfde tipe reaksies, kan nie van enige enstowwe gesê word, wat slegs vir ‘n jaar gaan geldig wees, die maskers en grendels gaan nie verdwyn nie. Inhoud van entstowwe is so vaag en mense met allergiese toestande het probleme om so ‘n middel te gebruik as die ware inhoud nie gegee word nie. Hoe betroubaar kan dit wees? Ons gaan steeds beperk wees soos tans die geval is.
Dis nie regtig net ‘n teorie in naam nie. Dis nie ‘n middel wat ‘n dag oud is nie, maar vir dekades. Vir dekades is dit op die Afrika kontinent en ander plekke gebruik. Dit is die werklikheid en realiteit, daar is mediese deurbrake reeds oortref en behaal met Ivermectin, dis deur van die dokters in verskeie hospitale en hul baie siek pasiënte gebruik met goeie resultate. Meeste van die dokters gee ook die presiese inhoud en wat hul gebruik saam met Ivermectin. Die resultate is ongelooflik goed.
Daar is geen waarborge met enige entstowwe wat net vir ‘n jaar van krag gaan wees en of dat dit gevrywaar is teen dieselfde virus of nuwes wat ontwikkel nie.
TLU SA relies on proven scientific facts to make any decisions. Given the available scientific information, the government should give strong guidelines for individuals to apply themselves to manage the COVID-19 pandemic.
“The government prefers to take South Africa back to level three of the lockdown and harm the economy even further instead of doing research and finding solutions,” says Mr Henry Geldenhuys, the president of TLU SA. “Why does the government choose not to investigate alternative solutions in the war against the coronavirus?” The government’s apathy towards the use of Ivermectin – a medicine used against various infections and in treating animals – creates distrust since the proven successes are widely published. The government should fire on all cylinders to gather as much scientifically proven facts about Ivermectin and test it. If it proves successful, the government should encourage its use.
“The economy can only continue to function well if the government realises that there are certain practical implications relating to the value chain,” says Mr Geldenhuys. “When you limit one economic activity, it automatically and immediately affects other parts of the economy. Unemployment, the closure of smaller businesses and the poverty it creates are a part of the daily South African life. Only economic growth can successfully improve it.”
The government is quick to decree regulations which do not make any sense. This leads to South Africans questioning the judgement of the government. The corruption around and mismanagement of funds earmarked for the pandemic’s management and relief further broke down the government’s credibility. To apologise and slightly reprimand the guilty, do not boost trust.
“The government must show greater fairness and transparency in their actions,” says Mr Geldenhuys. “Now is not the time to make assistance a political game. For example, to donate R1,2 billion to the farmers who only produce 1% of the food basket is unreasonable and illogical.”
“COVID-19 will not disappear after 15 January or even soon after that. Creating a balance in the approach to aspects which threaten us is critical. To do that, we need capacity in state revenue to curb these types of threats. That can only happen if the economy functions and grows.” The commercial agricultural sector will continue to produce food to stabilise the country. The government should give them the needed recognition and support.
There has, in recent times, been a lot of media attention on the effectiveness of the treatment of Covid-19 with Ivermectin.
A number of scientific articles support this theory, and a USA leading pulmonologist is pleading with the FDA to recognize the usefulness of Ivermectin in the prevention and treatment of Covid-19 infection. Our animal health Ivermectin products are not registered as human medicine.
Our registered stock remedies have been tested for safety in animals, not humans. It is a criminal act to recommend the use in humans of animal health products (stock remedies or Veterinary Medicines) that are not registered as medicines for use in or on humans for any purpose, in accordance with Act 101 of 1965. Afrivet does not recommend the use, in or on humans, of any of our products that contain Ivermectin – whether they be stock remedies or Veterinary Medicines.
Afrivet provides animal health products, knowledge solutions and services for animal owners, farmers and veterinarians in Africa.
Our locally and internationally developed and tested products prevent and treat disease in animals and promote food security and safety.
6 APRIL 2020
A study has demonstrated that the anti-parasitic drug ivermectin may be effective against SARS-CoV-2, the virus which causes COVID-19.
Researchers have discovered ivermectin, an anti-parasitic drug found world-wide, can kill SARS-CoV-2, the virus causing the COVID-19 pandemic, within 48 hours.
A collaborative study by Monash University’s Biomedicine Discovery Institute (BDI) and the Peter Doherty Institute of Infection and Immunity (Doherty Institute), both Australia, demonstrated that ivermectin can stop SARS-CoV-2 growth in cell cultures by eradicating all genetic information within two days. Their findings were published in Antiviral Research.
“We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” said BDI’s Dr Kylie Wagstaff, who led the study.
Ivermectin is a US Food and Drug Administration (FDA)-approved anti-parasitic drug that has previously shown activity in vitro against a broad range of viruses, including human immunodeficiency virus (HIV), Dengue fever, influenza and Zika virus. Dr Wagstaff stated: “Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective – that’s the next step.”
According to Dr Wagstaff, the mechanism of action by which ivermectin targets SARS-CoV-2 is unknown; however, it is thought to be similar to how it works on other viruses – preventing the virus dampening down the host cells’ ability to clear it.
Dr Wagstaff worked with Professor David Jans, also an author on the paper, to conduct the research. Professor Jans and his team have been researching ivermectin’s antiviral properties for more than 10 years with different viruses. The pair said they began their work on SARS-CoV-2 as soon as the pandemic was reported to have started.
Dr Wagstaff concluded by cautioning that the use of ivermectin to combat the COVID-19 pandemic will depend on further pre-clinical and clinical testing which will require funding.
(FOLLOW COMMENTS AS WELL)
22 JUNE 2020
A recent study reported that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells, and two preprint publications reported observational clinical studies on the apparent utility of ivermectin to treat patients with COVID-19 needing mechanical ventilation. However, none of these studies was peer-reviewed nor formally published and one study was later retracted. The Pan American Health Organization (PAHO) compiled an evidence database of potential COVID-19 therapeutics for which a rapid review was conducted of all COVID-19 in vitro (lab) and in vivo (clinical) human studies published from January to May 2020. The review concluded that the studies on ivermectin were found to have a high risk of bias, very low certainty of the evidence, and that the existing evidence is insufficient to draw a conclusion on benefits and harms. Though the effectiveness of ivermectin is currently being evaluated in various randomized clinical trials, the World Health Organization (WHO) excluded ivermectin from its co-sponsored Solidarity Trial for COVID-19 treatments, a global effort to find an effective treatment for COVID-19.
The Mectizan® (ivermectin) Expert Committee Statement on Potential Efficacy of Ivermectin on COVID-19 emphasized that the laboratory results showing efficacy of ivermectin to reduce viral loads in laboratory cultures, at dosage levels far beyond those approved by the FDA for treatment of parasitic diseases in humans, are not sufficient to indicate that ivermectin will be of clinical benefit to reduce viral loads in COVID-19 patients. Chaccour et al. caution against using in vitro findings as more than a qualitative indicator of potential efficacy and emphasize that “due diligence and regulatory review are needed before testing ivermectin in COVID-19.